(Q54405936)

29 May 2018

title

Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis. (English)

1 reference

29 May 2018

6

Gunhild M Mælandsmo

1 reference

29 May 2018

author name string

Gisle Berge

1

1 reference

29 May 2018

Solveig Pettersen

2

1 reference

29 May 2018

Ida Grotterød

3

1 reference

29 May 2018

Ingrid J Bettum

4

1 reference

29 May 2018

Kjetil Boye

5

1 reference

29 May 2018

language of work or name

English

0 references

publication date

11 March 2011

1 reference

29 May 2018

International Journal of Cancer

published in

1 reference

29 May 2018

volume

129

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

780-790

1 reference

29 May 2018

Intracellular and extracellular roles of S100 proteins

cites work

1 reference

Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.

21 January 2018

1 reference

The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor

21 January 2018

1 reference

S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases.

21 January 2018

1 reference

Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity

21 January 2018

1 reference

Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay

21 January 2018

1 reference

Activation of NF-kappaB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes

21 January 2018

1 reference

Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.

21 January 2018

1 reference

Osteopontin: regulation in tumor metastasis

21 January 2018

1 reference

Role of osteopontin in cellular signaling and metastatic phenotype

21 January 2018

1 reference

Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation

21 January 2018

1 reference

Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells

21 January 2018

1 reference

Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent

21 January 2018

1 reference

S100A4, a mediator of metastasis

21 January 2018

1 reference

Osteopontin: an effector and an effect of tumor metastasis.

21 January 2018

1 reference

Cancer invasion and metastasis: changing views.

21 January 2018

1 reference

Urokinase-type plasminogen activator

21 January 2018

1 reference

The structure, regulation, and function of human matrix metalloproteinase-13

21 January 2018

1 reference

Evolving role of uPA/uPAR system in human cancers

21 January 2018

1 reference

New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells

21 January 2018

1 reference

S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells

21 January 2018

1 reference

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients.

21 January 2018

1 reference

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

21 January 2018

1 reference

Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators

21 January 2018

1 reference

Matrix metalloproteinases: role in arthritis

21 January 2018

1 reference

Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis

21 January 2018

1 reference

Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells

21 January 2018

1 reference

The inhibition of in vivo tumorigenesis of osteosarcoma (OS)-732 cells by antisense human osteopontin RNA.

21 January 2018

1 reference

Matrix metalloproteinases participate in osteosarcoma invasion

21 January 2018

1 reference

A small interfering RNA targeting osteopontin as gastric cancer therapeutics

21 January 2018

1 reference

Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435

21 January 2018

1 reference

Systemic endocrine instigation of indolent tumor growth requires osteopontin

21 January 2018

1 reference

Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25735

1 reference

29 May 2018

PubMed ID

20957651

1 reference

29 May 2018